Spotlight
Topic
News
Opinion
Brand Insights
Subscribe
Advertise
- Strategy
- Payers
- AI
- Cybersecurity
- Device Development
- Studies/Published Research
- Ethics
- Regulatory
- Digital Biomarkers
- Data Science
- Companion Diagnostics
- Clinical Care
- Digital Therapeutics
- Academic Research
- Virtual Reality
- RWE
- Digital Endpoints
- Medical Devices (Class II and Class III)
- Commercialization
- Clinical Trials
- Drug-Device Combinations
- SaMD
- Remote Patient Monitoring
- Patient Engagement
- Profiles/Q&A
Curebase Launches Software Package for DTx Trials
Curebase has announced the release of its integrated software and services package for digital therapeutics (DTx) trials. Available now, the new offering includes a DCT platform bundled with site and trial execution services for the DTx market.
This blend of eClinical software and technology-driven services enables sponsors of DTx studies to leverage the following Curebase capabilities:
- Technology and virtual site models
- Site services
- Start-to-finish execution
Read more about the new offering here.
Related Videos
Related Content
